尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Garber Alan M, 董事. Officer active across 2 companies, notably Exelixis, INC.. Aggregated, 6 disclosures have been logged. History available since 1 March 2022. The latest transaction was filed on 1 May 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Garber Alan M is Administrateur and has filed 6 filings in total. Among the recent filings held, they cover the period from 2016-01-05 to 2025-05-05, with transactions of the Attribution type, and the companies mentioned are Exelixis, INC. and Vertex Pharmaceuticals INC / MA.